Original paper
A Multi-Institutional Estimation of Interobserver Variability in Glioblastoma Delineation in the EORTC-1709-BTG /CCTG CE.8 Trial
Volume: 105, Issue: 1, Pages: E617 - E618
Published: Sep 1, 2019
Abstract
Standard of care for glioblastoma (GBM) is maximal resection, radiotherapy (RT) + temozolomide (TMZ) followed by adjuvant TMZ (EORTC / NCIC 26981-22981 trial). For years, RT for GBM is conformal/modulated, volume-based with rigorous delineation guidelines for target and organs at risk (OARs) based on imaging (CT-MR). It is expected that the interobserver variability in delineation/planning would be limited. The EORTC 1709-BTG/CCTG CE.8 trial is...
Paper Details
Title
A Multi-Institutional Estimation of Interobserver Variability in Glioblastoma Delineation in the EORTC-1709-BTG /CCTG CE.8 Trial
Published Date
Sep 1, 2019
Volume
105
Issue
1
Pages
E617 - E618
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History